TOP STORIES

• BUSINESS Tokyo Prosecutors File Appeal in Diovan Case
  March 30, 2017

• BUSINESS Mitsubishi Tanabe to Pull Plug on Generics, Transfer Biz to Nipro in October
  March 29, 2017

• ORGANIZATION Wholesalers to Address Product Return Issue after Fake Harvoni Case: JPWA Chair
  March 28, 2017

• ORGANIZATION Vaccine Association to Standardize Presentation of Expiration Dates above Inspection Dates on Outer Packaging
  March 27, 2017

• BUSINESS Wholesale Dealer President Deeply Sorry for Letting Fake Harvoni into Supply Chain
  March 24, 2017

• TRENDS As Takeda’s R&D Rejig Progresses, Biotech JV Launch Sets Direction for Its Japan Regime
  March 23, 2017

• BUSINESS Japan Begins Using PD-L1 Expression Biomarker for Immune Checkpoint Inhibitors, but Challenges Linger
  March 22, 2017

• ORGANIZATION Study Group Presents Proposal for Future Vision for Kampo Medicines
  March 21, 2017

• BUSINESS Court Finds Data Manipulation, but Not False Advertising: Diovan Case
  March 17, 2017

• BUSINESS Novartis, Ex-Employee Found Not Guilty in Diovan Case
  March 16, 2017

• REGULATORY Chuikyo Begins Debate on Gap-Year Price Revisions; Industry Frets Advance Announcement of Discrepancy Threshold
  March 16, 2017

• BUSINESS Takeda Biotech JV to Focus on 8 Projects for Now, Eyes IPO: CEO Okumura
  March 15, 2017

• REGULATORY Celgene Faces Biz Improvement Order over Delays in Side Effect Reporting
  March 15, 2017

• BUSINESS INCJ, Takeda, Medipal to Form Biotech Venture
  March 14, 2017

• BUSINESS 1st Line Use, Administration Interval Will Be Key Differentiator for Keytruda: MSD Japan Chief
  March 14, 2017

• REGULATORY Tokyo, Osaka Govts Issue Biz Improvement Order to Dealers over Fake Harvoni
  March 14, 2017

• REGULATORY Reference Pricing on Agenda for CEFP Social Security Working Group
  March 10, 2017

• BUSINESS Pfizer’s FY2016 Japan Sales Slide 7.4% on Price Cuts, Generic Erosions
  March 9, 2017

• REGULATORY MHLW to Set Up Panel on Drug Distribution after Fake Harvoni Flub, Eyes GDP Ordinance
  March 8, 2017

• REGULATORY Tap Real-World Data for Optimal Use of High-Priced Meds: MHLW Bureau Chief
  March 7, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• …
• Next ›
• 最終 »